In contrast, patients without previous GVHD showed relatively strong responses for all three cell subsets only for mTOR (Ser2448), while the AKT (Thr308) and STAT3 (Ser727) responses were usually less significant for CD3+CD8+ cells. The gene discussed is CD8A; the disease is graft versus host disease.